The DOI matches its Crossref record; 82 of the 95 references it cites were found in a registry or an index.
Multicomponent Analysis of the Pancreatic Adenocarcinoma Progression Model Using a Pancreatic Intraepithelial Neoplasia Tissue Microarray
Open accessAbstract
A multistep model for pancreatic adenocarcinoma has been proposed recently. In this model, well-defined, noninvasive ductal lesions are recognized as precursors of invasive cancer and have been classified under the nomenclature of pancreatic intraepithelial neoplasia, or PanIN. Increasing evidence suggests that PanINs represent true neoplasms of the pancreatic ductal epithelium, accumulating histologic and genetic abnormalities in their progression toward invasive cancer. We have constructed a tissue microarray containing 55 PanIN lesions of all histologic grades in order to perform a multicomponent analysis of the pancreatic adenocarcinoma progression model. The protein products of 14 genes encompassing a variety of functional classes, such as tumor suppressor genes (p53, Smad4/Dpc4), oncogenes (beta-catenin), cell cycle antigens (p16, cyclin D1), proliferation antigens (Ki-67, topoisomerase II alpha), and epithelial apomucins (MUC1, MUC2, MUC5), as well as "novel" genes described as differentially up-regulated in invasive pancreas cancer by global microarray expression analysis (mesothelin, prostate stem cell antigen, fascin, and 14-3-3varsigma), were analyzed by immunohistochemistry on the PanIN tissue microarray. Comparison of the results from the current study with previously published data performed on routine histologic sections of PanINs demonstrates that tissue microarrays are a valid platform for molecular analysis not only of invasive cancers but of precursor lesions as well. In addition, this study demonstrates that molecular abnormalities in PanINs are not random but can usually be stratified into "early" changes (e.g., expression of MUC5 and prostate stem antigen, or loss of p16), "intermediate" changes (e.g., expression of cyclin D1), and "late" changes (e.g., expression of p53, proliferation antigens, MUC1, mesothelin, and 14-3-3varsigma, or loss of Smad4/Dpc4). Understanding the molecular pathogenesis of precursor lesions of invasive pancreatic adenocarcinomas using a high-throughput tissue microarray-based approach is a valuable adjunct to designing rational strategies for early detection of this lethal neoplasm.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Early molecular profiling coupled with histology allowed for the development of a putative pathological progression model; analogous to the adenoma-carcinoma model in the colon23”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [23]
In the citing paper
“The temporal appearance of these alterations during multistep progression suggests that TP53 and SMAD4 typically occur late, usually in the setting of high-grade lesions or cancer in both PanINs and IPMNs23,51.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [23]
In the citing paper
“For example, approximately 40% of pancreatic ductal adenocarcinomas have mutated TP53 and deleted ARF (Heinmoller, et al., 2000; Hustinx, et al., 2005; Maitra, et al., 2003).”
From The Mdm network and its regulation of p53 activities: a rheostat of cancer risk (2014) · cites this paper as Maitra, et al., 2003
Citations
Cites
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Kononen, J., Bubendorf, L., Kallionimeni, A., Barlund, M. T., Schraml, P., Leighton, S. B., Torhorst, J. K. H., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,101
Greenlee, R. T., Hill-Harmon, M. B., Murray, T., & Thun, M. J. (2001) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.1.15 · Cited by 3,281
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337
Self-citationDelineation of prognostic biomarkers in prostate cancer
Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R. B., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2001) · Nature · doi:10.1038/35090585 · Cited by 1,675
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
Hruban, R. H., Adsay, N. V., Albores–Saavedra, J., Compton, C., Garrett, E. S., Goodman, S. N., Kern, S. E., Klimstra, D. S., Klöppel, G., Longnecker, D. S., et al. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200105000-00003 · Cited by 1,126
Self-citationSpecific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
Progression model for pancreatic cancer.
Hruban, R. H., Goggins, M., Parsons, J., & Kern, S. E. (2000) · PubMed · Cited by 872
Self-citationChang, K., & Pastan, I. H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.136 · Cited by 747
Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer
Reiter, R. E., Gu, Z., Watabe, T., THOMAS, G. V., Szigeti, K., Davis, E., Wahl, M. I., Nisitani, S., Yamashiro, J. M., Beau, M. M. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1735 · Cited by 675
Cited by
Sorted by citations
Kamisawa, T., Wood, L. D., Itoi, T., & Takaori, K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00141-0 · Cited by 2,212
Genetics and biology of pancreatic ductal adenocarcinomaPreprint
Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N. M., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,611
Pancreatic cancer: Advances and challenges
Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321
Self-citationHruban, R. H., Takaori, K., Klimstra, D. S., Adsay, N. V., Albores-Saavedra, J., Biankin, A. V., Biankin, S. A., Compton, C., Fukushima, N., Furukawa, T., et al. (2004) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000126675.59108.80 · Cited by 1,091
Self-citationPhenotype and Genotype of Pancreatic Cancer Cell Lines
Deer, E. L., González-Hernández, J., Coursen, J. D., Shea, J. E., Ngatia, J., Scaife, C. L., Firpo, M. A., & Mulvihill, S. J. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181c15963 · Cited by 936
Maitra, A., & Hruban, R. H. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154305 · Cited by 707
Self-citationMutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer
Morton, J. P., Timpson, P., Karim, S. A., Ridgway, R. A., Athineos, D., Doyle, B., Jamieson, N. B., Oien, K. A., Lowy, A. M., Brunton, V. G., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908428107 · Cited by 657
Bardeesy, N. M., Aguirre, A. J., Chu, G. C., Cheng, K., Lopez, L. V., Hezel, A. F., Feng, B., Brennan, C., Weissleder, R., Mahmood, U., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601273103 · Cited by 584
KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma
Morris, J. P., Wang, S. C., & Hebrok, M. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2899 · Cited by 597
Gironella, M., Seux, M., Xie, M.-J., Cano, C. E., Tomasini, R., Gommeaux, J., Garcia, S., Nowak, J., Yeung, M. L., Jeang, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703942104 · Cited by 548
Independence and reproducibility across microarray platforms
Larkin, J. E., Frank, B. C., Gavras, H. P., Sultana, R., & Quackenbush, J. F. (2005) · Nature Methods · doi:10.1038/nmeth757 · Cited by 422
Iacobuzio–Donahue, C. A., Ashfaq, R., Maitra, A., Adsay, V. N., Shen-Ong, G. L. C., Berg, K. D., Hollingsworth, M. A., Cameron, J. L., Yeo, C. J., Kern, S. E., et al. (2003) · PubMed · Cited by 415
Self-citationInfante, J. R., Matsubayashi, H., Sato, N., Tonascia, J., Klein, A. P., Riall, T. S., Yeo, C. J., Iacobuzio–Donahue, C. A., & Goggins, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.8824 · Cited by 413
Self-citationChiyomaru, T., Enokida, H., Tatarano, S., Kawahara, K., Uchida, Y., Nishiyama, K., Fujimura, L., Kikkawa, N., Seki, N., & Nakagawa, M. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605570 · Cited by 324
Stromal biology of pancreatic cancer
Chu, G. C., Kimmelman, A. C., Hezel, A. F., & DePinho, R. A. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21209 · Cited by 330
Hedgehog/Ras interactions regulate early stages of pancreatic cancerPreprint
di Magliano, M. P., Sekine, S., Ermilov, A. N., Ferris, J., Dlugosz, A. A., & Hebrok, M. (2006) · Genes & Development · doi:10.1101/gad.1470806 · Cited by 302
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia
Habbe, N., Koorstra, J.-B. M., Mendell, J. T., Offerhaus, G. J. A., Ryu, J. K., Feldmann, G., Mullendore, M. E., Goggins, M., Hong, S., & Maitra, A. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.4.7338 · Cited by 301
Self-citationMino-Kenudson, M. A., Castillo, C. F.-D., Baba, Y., Valsangkar, N. P., Liss, A. S., Hsu, M., Correa‐Gallego, C., Ingkakul, T., Johnston, R. P., Turner, B. G., et al. (2011) · Gut · doi:10.1136/gut.2010.232272 · Cited by 292
Precursors to Invasive Pancreatic Cancer
Maitra, A., Fukushima, N., Takaori, K., & Hruban, R. H. (2005) · Advances in Anatomic Pathology · doi:10.1097/01.pap.0000155055.14238.25 · Cited by 290
Self-citationRoles of fascin in human carcinoma motility and signaling: Prospects for a novel biomarker?
Hashimoto, Y., Skacel, M., & Adams, J. C. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.05.004 · Cited by 281
Molecular genetics of pancreatic intraepithelial neoplasia
Feldmann, G., Beaty, R., Hruban, R. H., & Maitra, A. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1166-5 · Cited by 269
Self-citationPommier, A., Anaparthy, N., Memos, N. K., Kelley, Z. L., Gouronnec, A., Yan, R., Auffray, C., Albrengues, J., Egeblad, M., Iacobuzio–Donahue, C. A., et al. (2018) · Science · doi:10.1126/science.aao4908 · Cited by 269
Self-citationPhilip, B., Roland, C. L., Daniluk, J., Liu, Y., Chatterjee, D., Gomez, S., Ji, B., Huang, H., Wang, H., Fleming, J. B., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.018 · Cited by 252
Update on pancreatic intraepithelial neoplasia.
Hruban, R. H., Maitra, A., & Goggins, M. (2008) · PubMed Central · Cited by 245
Self-citationPrasad, N. B., Biankin, A. V., Fukushima, N., Maitra, A., Dhara, S., ELKAHLOUN, A. G., Hruban, R. H., Goggins, M., & Leach, S. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1413 · Cited by 240
Self-citationMolecular Pathogenesis of Pancreatic Cancer
Grant, T. J., Hua, K., & Singh, A. (2016) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2016.09.008 · Cited by 237
Pancreatic cancer microenvironment
Kleeff, J. H., Beckhove, P., Esposito, I., Herzig, S., Huber, P. E., Löhr, M. J., & Friess, H. (2007) · International Journal of Cancer · doi:10.1002/ijc.22871 · Cited by 222
Nielsen, M. F. B., Mortensen, M. B., & Detlefsen, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i9.2678 · Cited by 228
Precursor Lesions for Sporadic Pancreatic Cancer: PanIN, IPMN, and MCN
Distler, M., Aust, D. E., Weitz, J., Pilarsky, C. P., & Grützmann, R. (2014) · BioMed Research International · doi:10.1155/2014/474905 · Cited by 219
Yamaguchi, H., Shimizu, M., Ban, S., Koyama, I., Hatori, T., Fujita, I., Yamamoto, M., Kawamura, S., Kobayashi, M., Ishida, K., et al. (2009) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181a162e5 · Cited by 213
MicroRNA Alterations of Pancreatic Intraepithelial Neoplasias
Yu, J., Li, A., Hong, S., Hruban, R. H., & Goggins, M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2347 · Cited by 212
Self-citationMolecular pathogenesis of pancreatic cancer
Maitra, A., Kern, S. E., & Hruban, R. H. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.10.002 · Cited by 199
Self-citationTranscriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions
Buchholz, M., Braun, M., Heidenblut, A., Kestler, H. A., Klöppel, G., Schmiegel, W., Hahn, S. A., Lüttges, J., Gress, T. M., & Krebshilfe, F. T. G. P. C. N. O. T. D. (2005) · Oncogene · doi:10.1038/sj.onc.1208804 · Cited by 190
Omori, Y., Ono, Y., Tanino, M. A., Karasaki, H., Yamaguchi, H., Furukawa, T., Enomoto, K., Ueda, J., Sumi, A., Katayama, J., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.10.029 · Cited by 189
Koorstra, J.-B. M., Hustinx, S. R., Offerhaus, G. J. A., & Maitra, A. (2008) · Pancreatology · doi:10.1159/000123838 · Cited by 191
Self-citationMesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer
Li, M., Bharadwaj, U., Zhang, R., Zhang, S., Mu, H. H., Fisher, W. E., Brunicardi, F. C., Chen, C., & Yao, Q. C. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0483 · Cited by 178
Proteomic Analysis of Chronic Pancreatitis and Pancreatic Adenocarcinoma
Crnogorac‐Jurcevic, T., Gangeswaran, R., Bhakta, V., Capurso, G., Lattimore, S., Akada, M., Sunamura, M., Prime, W., Campbell, F., Brentnall, T. A., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.08.012 · Cited by 170
Mucin expression profile in pancreatic cancer and the precursor lesions
Nagata, K., Horinouchi, M., Saitou, M., Higashi, M., Nomoto, M., Goto, M., & Yonezawa, S. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1169-2 · Cited by 167
Ban, S., Naitoh, Y., Mino-Kenudson, M. A., Sakurai, T., Kuroda, M., Koyama, I., Lauwers, G. Y., & Shimizu, M. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213305.98187.d4 · Cited by 165
Strobel, O., Rosow, D. E., Rakhlin, E. Y., Lauwers, G. Y., Trainor, A. G., Alsina, J., del Castillo, C. F., Warshaw, A. L., & Thayer, S. P. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.12.005 · Cited by 162
Pathology and Molecular Genetics of Pancreatic Neoplasms
Wood, L. D., & Hruban, R. H. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e31827459b6 · Cited by 168
Self-citationHosoda, W., Chianchiano, P. E., Griffin, J. F., Pittman, M. E., Brosens, L. A. A., Noë, M., Yu, J., Shindo, K., Suenaga, M., Rezaee, N., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4884 · Cited by 158
Self-citationBarriers and opportunities for gemcitabine in pancreatic cancer therapy
Beutel, A. K., & Halbrook, C. J. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00331.2022 · Cited by 150
Precursor Lesions of Pancreatic Cancer: Molecular Pathology and Clinical Implications
Singh, M., & Maitra, A. (2007) · Pancreatology · doi:10.1159/000101873 · Cited by 148
Self-citationSeki (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.919 · Cited by 145
Genetically Engineered Mouse Models of Pancreatic Cancer
Westphalen, C. B., & Olive, K. P. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e31827ab4c4 · Cited by 140
Ryu, J. K., Hong, S., Karikari, C. A., Hruban, R. H., Goggins, M., & Maitra, A. (2010) · Pancreatology · doi:10.1159/000231984 · Cited by 145
Self-citationTeng, K., Mansour, A. G., Zhu, Z. G., Li, Z., Tian, L., Ma, S., Xu, B., Lu, T., Chen, H., Hou, D., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.281 · Cited by 136
Hashimoto, Y., Skacel, M., Lavery, I. C., Mukherjee, A. L., Casey, G., & Adams, J. C. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-241 · Cited by 133
Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment
Sukumaran, S., Watanabe, N., Bajgain, P., Raja, K., Mohammed, S., Fisher, W. E., Brenner, M. K., Leen, A. M., & Vera, J. F. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1298 · Cited by 130
Furukawa, T., Fujisaki, R., Yoshida, Y., Kanai, N., Sunamura, M., Abe, T., Takeda, K., Matsuno, S., & Horii, A. (2005) · Modern Pathology · doi:10.1038/modpathol.3800383 · Cited by 128
Hustinx, S. R., Leoni, L. M., Yeo, C. J., Brown, P. N., Goggins, M., Kern, S. E., Hruban, R. H., & Maitra, A. (2005) · Modern Pathology · doi:10.1038/modpathol.3800377 · Cited by 125
Self-citationLiao, D. J., Thakur, A. B., Wu, J., Biliran, H., & Sarkar, F. H. (2007) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v13.i2.10 · Cited by 116
Pancreatic Intraepithelial Neoplasia
Takaori, K., Hruban, R. H., Maitra, A., & Tanigawa, N. (2004) · Pancreas · doi:10.1097/00006676-200404000-00008 · Cited by 116
Self-citationCurrent Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions
Brunner, M., Wu, Z., Krautz, C., Pilarsky, C. P., Grützmann, R., & Weber, G. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184543 · Cited by 121
Li, A., Morton, J. P., Ma, Y., Karim, S. A., Zhou, Y., Faller, W. J., Woodham, E. F., Morris, H., Stevenson, R. P., Juin, A., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.046 · Cited by 117
Haque, I., Mehta, S., Majumder, M., Dhar, K., De, A., McGregor, D., Van Veldhuizen, P. J., Banerjee, S. K., & Banerjee, S. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-8 · Cited by 113
Herner, A., Sauliunaite, D., Michalski, C. W., Erkan, M., Oliveira, T. D., Abiatari, I., Kong, B., Esposito, I., Frieß, H., & Kleeff, J. H. (2011) · International Journal of Cancer · doi:10.1002/ijc.25898 · Cited by 113
Henke, R. T., Haddad, B. R., Kim, S. E., Rone, J. D., Mani, A., Jessup, J. M., Wellstein, A., Maitra, A., & Riegel, A. T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0561 · Cited by 113
Self-citationPancreatic Intraepithelial Neoplasia Revisited and Updated
Sipos, B., Frank, S., Gress, T. M., Hahn, S. A., & Klöppel, G. (2008) · Pancreatology · doi:10.1159/000178874 · Cited by 112
Claudin-18 Is an Early-Stage Marker of Pancreatic Carcinogenesis
Tanaka, M. H., Shibahara, J., Fukushima, N., Shinozaki‐Ushiku, A., Umeda, M., Ishikawa, S., Kokudo, N., & Fukayama, M. (2011) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155411420569 · Cited by 107
Tinder, T. L., Subramani, D. B., Basu, G. D., Bradley, J. M., Schettini, J. L., Arefayene, M., Skaar, T. C., & Mukherjee, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3116 · Cited by 108
Bharadwaj, U., Li, M., Chen, C., & Yao, Q. C. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0095 · Cited by 109
Merlin, J., Stechly, L., de Beauce, S., Monté, D., Leteurtre, E., SEUNINGEN, I. V., Huet, G., & Pigny, P. (2011) · Oncogene · doi:10.1038/onc.2010.631 · Cited by 105
Schoedel, K. E., Finkelstein, S. D., & Ohori, N. P. (2006) · Diagnostic Cytopathology · doi:10.1002/dc.20511 · Cited by 105
Longnecker, D. S., Adsay, V. N., Castillo, C. F. F.-D., Hruban, R. H., Kasugai, T., Klimstra, D. S., Kl??ppel, G., L�ttges, J., Memoli, V. A., Tosteson, T. D., et al. (2005) · Pancreas · doi:10.1097/01.mpa.0000186245.35716.18 · Cited by 102
Self-citationQiu, W., Sahin, F., Iacobuzio-Donahue, C. A., Garcia-Carracedo, D., Wang, W. M., Kuo, C.-Y., Chen, D., Arking, D. E., Lowy, A. M., Hruban, R. H., et al. (2011) · Oncotarget · doi:10.18632/oncotarget.357 · Cited by 99
Self-citationCao, D., Maitra, A., Saavedra, J.-A., Klimstra, D. S., Adsay, V. N., & Hruban, R. H. (2005) · Modern Pathology · doi:10.1038/modpathol.3800363 · Cited by 98
Self-citationSMAD4 and its role in pancreatic cancer
Xia, X., Wu, W., Huang, C., Cen, G., Jiang, T., Cao, J., Huang, K., & Qiu, Z. (2014) · Tumor Biology · doi:10.1007/s13277-014-2883-z · Cited by 98
Xue, L., Hu, N., Song, Y., Zou, S., Shou, J., Qian, L.-X., Ren, L.-Q., Lin, D., Tong, T., He, Z.-G., et al. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-296 · Cited by 95
Biankin, A. V., Kench, J. G., Biankin, S. A., Lee, C.-S., Morey, A. L., Dijkman, F. P., Coleman, M. J., Sutherland, R. L., & Henshall, S. M. (2004) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000131556.22382.3c · Cited by 94
CEACAM6 Is a Novel Biomarker in Pancreatic Adenocarcinoma and PanIN Lesions
Duxbury, M. S., Matros, E., Clancy, T. E., Bailey, G., Doff, M., Zinner, M. J., Ashley, S. W., Maitra, A., Redston, M. S., & Whang, E. E. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000154455.86404.e9 · Cited by 94
Self-citationPAM4-Reactive MUC1 Is a Biomarker for Early Pancreatic Adenocarcinoma
Gold, D. V., Karanjawala, Z., Modrak, D. E., Goldenberg, D. M., & Hruban, R. H. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1488 · Cited by 93
Self-citationPharmacogenetics of anticancer drug sensitivity in pancreatic cancer
Giovannetti, E., Mey, V., Nannizzi, S., Pasqualetti, G., Tacca, M. D., & Danesi, R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0004 · Cited by 93
Locally Advanced Pancreatic Cancer: A Review of Local Ablative Therapies
Ruarus, A. H., Vroomen, L. G. P. H., Puijk, R. S., Scheffer, H. J., & Meijerink, M. R. (2018) · Cancers · doi:10.3390/cancers10010016 · Cited by 87
Thomas, A., Chen, Y., Steinberg, S. M., Luo, J., Pack, S., Raffeld, M. A., Abdullaev, Z., Alewine, C., Rajan, A., Giaccone, G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3429 · Cited by 84
Porta, M. S., Crous‐Bou, M., Wark, P. A., Vineis, P., Real, F. X., Malats, N., & Kampman, E. (2009) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2009.07.003 · Cited by 83
Precursor lesions in pancreatic cancer: morphological and molecular pathology
Scarlett, C. J., Salisbury, E., Biankin, A. V., & Kench, J. G. (2011) · Pathology · doi:10.1097/pat.0b013e3283445e3a · Cited by 85
Molecular mechanism of pancreatic cancer—understanding proliferation, invasion, and metastasis
Mihaljević, A. L., Michalski, C. W., Friess, H., & Kleeff, J. H. (2010) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-010-0622-5 · Cited by 83
Molecular Genetics of Pancreatic Neoplasms and Their Morphologic Correlates
Reid, M. D., Saka, B., Balcı, S., Goldblum, A., & Adsay, V. N. (2014) · American Journal of Clinical Pathology · doi:10.1309/ajcp0fkdp7envkev · Cited by 80
Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder
Tong, G., Yee, H. T., Chiriboga, L. A., Hernandez, O. J., & Waisman, J. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.05.005 · Cited by 80
The Mdm network and its regulation of p53 activities: a rheostat of cancer risk
Eischen, C. M., & Lozano, G. (2014) · Human Mutation · doi:10.1002/humu.22524 · Cited by 79
Current and future biomarkers for pancreatic adenocarcinoma
Loosen, S. H., Neumann, U. P., Trautwein, C., Roderburg, C., & Luedde, T. (2017) · Tumor Biology · doi:10.1177/1010428317692231 · Cited by 81
Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes.
Zhang, X., Shi, S., Zhang, B., Ni, Q., Yu, X., & Xu, J. (2018) · PubMed Central · Cited by 78
Rowley, M., Ohashi, A., Mondal, G., Mills, L., Yang, L., Zhang, L., Sundsbak, R. S., Shapiro, V. S., Muders, M. H., Smyrk, T. C., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.12.039 · Cited by 77
Genetic Progression of Pancreatic Cancer
Cowan, R. W., & Maitra, A. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000011 · Cited by 76
Self-citationSurcel, A., Schiffhauer, E. S., Thomas, D. G., Zhu, Q., DiNapoli, K. T., Herbig, M., Otto, O., West‐Foyle, H., Jacobi, A., Kräter, M., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3131 · Cited by 76
McIntyre, C. A., Lawrence, S., Richards, A. L., Chou, J. F., Wong, W., Capanu, M., Berger, M. F., Donoghue, M. T. A., Yu, K. H., Varghese, A. M., et al. (2020) · Cancer · doi:10.1002/cncr.33038 · Cited by 75
Self-citationBiliary intraepithelial neoplasia in patients without chronic biliary disease
Wu, T., Levy, M. L., Correa, A. M., Rosen, C. B. B., & Abraham, S. C. (2009) · Cancer · doi:10.1002/cncr.24471 · Cited by 74
Sitek, B., Sipos, B., Alkatout, İ., Poschmann, G., Stephan, C., Schulenborg, T., Marcus, K., Lüttges, J., Dittert, D., Baretton, G. B., et al. (2009) · Journal of Proteome Research · doi:10.1021/pr800890j · Cited by 73
Clinical importance of precursor lesions in the pancreas
Hruban, R. H., Takaori, K., Canto, M. I., Fishman, E. K., Campbell, K. A., Brune, K. A., Kern, S. E., & Goggins, M. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1170-9 · Cited by 73
Self-citationHeterogeneity and Targeting of Pancreatic Cancer Stem Cells
Penchev, V. R., Rasheed, Z. A., Maitra, A., & Matsui, W. H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3112 · Cited by 72
Self-citationMouse models of pancreatic cancer
Leach, S. D. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00337-4 · Cited by 72
Kimura, K., Satoh, K., Kanno, A., Hamada, S., Hirota, M., Endoh, M., Masamune, A., & Shimosegawa, T. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00369.x · Cited by 72
Deciphering the role of hedgehog signaling in pancreatic cancer
Gu, D., Kelly, E., & Xie, J. (2016) · Journal of Biomedical Research · doi:10.7555/jbr.30.20150107 · Cited by 70
Cunningham, S. C., Kamangar, F., Kim, M. P., Hammoud, S., Haque, R. M., Iacobuzio–Donahue, C. A., Maitra, A., Ashfaq, R., Hustinx, S. R., Heitmiller, R. E., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0539 · Cited by 70
Self-citationDhar, G., Mehta, S., Banerjee, S., Gardner, A., McCarty, B. M., Mathur, S. C., Campbell, D. R., Kambhampati, S., & Banerjee, S. K. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.02.012 · Cited by 69
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
Dunne, R. F., & Hezel, A. F. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.04.003 · Cited by 68
Pharmacological activation of myosin II paralogs to correct cell mechanics defects
Surcel, A., Ng, W. P., West‐Foyle, H., Zhu, Q., Ren, Y., Avery, L. B., Krenc, A. K., Meyers, D. J., Rock, R. S., Anders, R. A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412592112 · Cited by 69
Chen, Y., Zheng, B., Robbins, D. H., Lewin, D., Mikhitarian, K., Graham, A. S., Rumpp, L., Glenn, T. F., Gillanders, W. E., Cole, D. J., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22487 · Cited by 66
Metadata
- Authors
- Maitra, A., Adsay, N. V., Argani, P., Iacobuzio-Donahue, C., De Marzo, A., Cameron, J. L., Yeo, C. J., & Hruban, R. H.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Maitra, Anirban
- Venue
- Modern Pathology
- Publisher
- Elsevier BV
- Published
- 2003-09
- Volume
- 16
- Issue
- 9
- Pages
- 902-912
- ISSN
- 0893-3952 (ISSN-L)
- OpenAlex
- W1980447806
- Cited by
- 429
- References
- 95
- Citations by year
- 2026: 12 · 2025: 12 · 2024: 13 · 2023: 18 · 2022: 11 · 2021: 16 · 2020: 11 · 2019: 14 · 2018: 24 · 2017: 16 · 2016: 13 · 2015: 16 · 2014: 22 · 2013: 19 · 2012: 24
- FWCI
- 8.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Modern Pathology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P50CA-62924, P50CA062924)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- pancreatic ductal adenocarcinoma, pancreatic intraepithelial neoplasia, tumor progression, precursor lesions, tissue microarray, molecular pathogenesis, p53, β-catenin, p16, cyclin D1, Ki-67, TOP2A, MUC1, MUC2, mesothelin, prostate stem cell antigen, fascin, 14-3-3 sigma, early detection
- MeSH terms
- Adenocarcinoma, Carcinoma in Situ, DNA, Neoplasm, Humans, Immunohistochemistry, Pancreatic Neoplasms, Precancerous Conditions, Biomarkers, Tumor, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
